Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,879,850
New position
Shares Held
42,500
first reported quarter
Ownership
0.073%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Maven Securities LTD holds $53,439,758 across 10 Biotechnology names. ACLX ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
375,000 | $19,770,000 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,109,882 | $16,048,893 | |
| 3 | ACLX |
Arcellx, Inc.
This page
|
42,500 | $4,879,850 | |
| 4 | ZBIO |
Zenas BioPharma, Inc.
|
150,000 | $2,932,500 | |
| 5 | KOD |
Kodiak Sciences Inc.
|
58,953 | $2,247,288 | |
| 6 | DAWN |
Day One Biopharmaceuticals, Inc.
|
103,900 | $2,227,616 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
25,000 | $2,104,250 | |
| 8 | OKYO |
OKYO Pharma Ltd
|
1,175,535 | $1,892,611 |
All Filings in ACLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,879,850 | 42,500 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||